Kimberly-Clark Closes $4.9 Billion Bond Sale Tied to Kenvue Deal
Kimberly-Clark has completed a $4.9 billion senior notes offering intended to finance its transaction involving Kenvue.
Kimberly-Clark has finalized a $4.9 billion senior notes offering, the consumer goods giant announced, with proceeds earmarked to support its pending deal with Kenvue, the consumer health company spun off from Johnson & Johnson.
The debt issuance represents a significant capital markets move for Kimberly-Clark, maker of Kleenex tissues and Huggies diapers, as it pursues the strategic transaction. Senior notes are unsecured debt instruments that rank ahead of other obligations in a company's capital structure, typically carrying lower interest rates than subordinated debt as a result.
Read more Wells Fargo Lifts CBOE Holdings Price Target to $357 →
The $4.9 billion raise underscores the scale of the Kenvue-related transaction and Kimberly-Clark's willingness to take on substantial leverage to advance its strategic agenda. Large bond offerings of this type are commonly used by corporations to lock in financing terms ahead of deal closings, reducing exposure to shifting credit market conditions.
Kenvue, which houses brands including Tylenol, Neutrogena, and Band-Aid, became an independent publicly traded company following its separation from Johnson & Johnson. Any acquisition or partnership involving such a portfolio would represent a material expansion of Kimberly-Clark's consumer product footprint beyond its core tissue and hygiene categories.
Full details of the transaction terms and the precise structure of the Kenvue deal were not disclosed in available reporting. Continue reading at All News.
